Boston Scientific MedSurg — Total assets of reportable segments remained flat by 0.0% to $3.39B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $3.09B to $3.39B.
Growth in assets relative to sales may indicate capital expansion, while a decline relative to sales might suggest improved asset turnover efficiency.
The total value of assets directly attributable to the MedSurg segment, including inventory, property, plant, equipment,...
Commonly reported as 'Segment Assets' in the notes to financial statements for diversified corporations.
bsx_segment_medsurg_total_assets_of_reportable_segments| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | $1.79B | $2.50B | $2.89B | $3.09B | $3.13B | $3.33B | $3.39B | $3.39B |
| QoQ Change | — | +39.4% | +15.5% | +7.1% | +1.1% | +6.5% | +1.8% | +0.0% |
| YoY Change | — | +39.4% | +15.5% | +7.1% | — | — | — | +9.7% |